

Description of Medical Areas
About the FDA Approved Listings
|
 |
Approved Drugs for Psychiatry/Psychology
Drugs Approved in 2008
No approvals recorded for Psychiatry/Psychology in 2008.
Drugs Approved in 2007
Drugs Approved in 2006
Chantix (varenicline); For the treatment of nicotine addiction; Pfizer; Approved May 2006
Drugs Approved in 2005
No approvals recorded for Psychiatry/Psychology in 2005.
Drugs Approved in 2004
Drugs Approved in 2003
No approvals recorded for Psychiatry/Psychology in 2003.
Drugs Approved in 2002
Abilify (aripiprazole); Oral drug for the treatment of schizophrenia; Bristol-Myers Squibb, Otsuka America Pharmaceutical; Approved November 2002
Geodon (ziprasidone mesylate); To control agitated behavior and psychotic symptoms in schizophrenia patients; Pfizer; Approved June 2002
Lexapro (escitalopram oxalate); An orally administered selective serotonin reuptake inhibitor useful for the treatment for major depressive disorder; Forest Laboratories; Approved August 2002
Paxil CR; Oral tablet for the treatment of depression and panic disorder; GlaxoSmithKline; Approved February 2002
Ritalin LA (methylphenidate HCl); Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD); Novartis; Approved June 2002
Strattera (atomoxetine HCl); For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults.; Eli Lilly; December 2002
Subutex/Suboxone (buprenorphine/naloxone); Oral tablets for the treatment of opiate dependence; Reckitt Benckiser; Approved October 2002
Zoloft (sertraline HCl); Oral tablets for the treatment of premenstrual dysphoric mood disorder (PMDD); Pfizer; Approved May 2002
Drugs Approved in 2001
Adderall XR; Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD); Shire Pharmaceuticals; Approved October 2001
Focalin (dexmethylphenidate HCl); For the treatment of attention deficit hyperactivity disorder (ADHD); Celgene; Approved November 2001
Metadate CD; Oral capsules for the treatment of attention deficit hyperactivity disorder; Celltech Pharmaceuticals; Approved April 2001
Prozac Weekly (fluoxetine HCl); For the treatment of depression; Eli Lilly; Approved February 2001
Remeron SolTab (mirtazapine); Orally disintegrating tablet for the treatment of depression; Organon; Approved January 2001
Drugs Approved in 2000
Concerta; For the treatment of Attention Deficit Hyperactivity Disorder; Alza; Approved August 2000
Drugs Approved in 1999
Effexor; Treatment for generalized anxiety disorder; Wyeth-Ayerst Laboratories; Approved March 1999
Paxil CR Tablets; Treatment for depression; SmithKline Beecham; Approved March 1999
Sonata; Treatment fo insomnia; American Home Products; Approved August 1999
Drugs Approved in 1998
Celexa; Treatment for depression; Forest Laboratories; Approved July 1998
Clomipramine hydrochloride; Generic equivalent of Anafranil; Mylan Laboratories; Approved April 1998
Cylert; Treatment for Attention Deficit Disorder; Abbott Laboratories; Approved October 1998
|
 |

Back to Centerwatch Drug Approvals
|